Value of RAPID3 in patients with PsA: results from the TICOPA and LOPAS II databases

類似資料

• Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC
  著者:: Coates, LC, 等
  出版事項: (2021)
• Lopás vagy lopás kísérlete?
  著者:: Szilárd Herman
  出版事項: (2015-06-01)
• Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC
  著者:: Coates, LC, 等
  出版事項: (2022)
• Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial
  著者:: Coates, L, 等
  出版事項: (2019)
• Ethical issues in a TwiCs study in early PsA
  著者:: Coates, L, 等
  出版事項: (2017)